Corrigendum to “Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support” [Biomed. Pharmacother. 174 (2024) 116530]

• Marta Moreno-Torres,
• Ernesto López-Pascual,
• Anna Rapisarda,
• Guillermo Quintás,
• Annika Drees,
• Inger-Lise Steffensen,
• Thomas Luechtefeld,
• Eva Serrano-Candelas,
• Marina Garcia de Lomana,
• Domenico Gadaleta,
• Hubert Dirven,
• Mathieu Vinken,
• Ramiro Jover

Affiliations

Marta Moreno-Torres

Joint Research Unit in Experimental Hepatology, Dep. Biochemistry and Molecular Biology, University of Valencia, Health Research Institute Hospital La Fe & CIBER of Hepatic and Digestive Diseases, Spain

Ernesto López-Pascual

Joint Research Unit in Experimental Hepatology, Dep. Biochemistry and Molecular Biology, University of Valencia, Health Research Institute Hospital La Fe & CIBER of Hepatic and Digestive Diseases, Spain

Anna Rapisarda

Joint Research Unit in Experimental Hepatology, Dep. Biochemistry and Molecular Biology, University of Valencia, Health Research Institute Hospital La Fe & CIBER of Hepatic and Digestive Diseases, Spain

Guillermo Quintás

Health and Biomedicine, LEITAT Technological Center, Barcelona, Spain

Annika Drees

Entity of In Vitro Toxicology and Dermato-Cosmetology, Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Belgium

Inger-Lise Steffensen

Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway

Thomas Luechtefeld

ToxTrack, Baltimore, MD, USA

Eva Serrano-Candelas

ProtoQSAR S.L., CEEI-Technology Park of Valencia, Paterna 46980, Spain

Marina Garcia de Lomana

Bayer AG, Machine Learning Research, Research & Development, Pharmaceuticals, Berlin 13353, Germany

Domenico Gadaleta

Laboratory of Environmental Toxicology and Chemistry, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCSS, Milano 20156, Italy

Hubert Dirven

Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway

Mathieu Vinken

Entity of In Vitro Toxicology and Dermato-Cosmetology, Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Belgium

Ramiro Jover

Joint Research Unit in Experimental Hepatology, Dep. Biochemistry and Molecular Biology, University of Valencia, Health Research Institute Hospital La Fe & CIBER of Hepatic and Digestive Diseases, Spain